From Bed to Bench: An Interview with Stephen Oesterle
Stephen Oesterle's mandate as senior vice president, medicine and technology and chief medical officer at Medtronic is nothing less than to help Medtronic chart a future course as technology and clinical developments force further change on the medical device industry. And daunting as that project is, few people appear better equipped for the challenge than Oesterle, who is known for his ability to combine an analytic mind with a capacious imagination-a combination well suited to embracing all aspects of the nexus of medicine and technology. This includes the convergence of medical technology and biotechnology, an area in which Oesterle has done as much as anyone in the industry to make happen for device companies.
You may also be interested in...
Medtronic has recruited physician opinion leaders for strategic management positions in most of its operating divisions. The company believes this strategy will help bring them closer to customers and expedite the bedside-to-bench process for developing new products.
Medtronic is the acknowledged leader in one of the hottest device sectors-neurostimulation-but even this giant struggles with problems of limited market penetration. So Medtronic is bringing a new approach to this area: an aggressive clinical trials strategy to differentiate its products and drive physician adoption. Who better to run the business than a clinical trials expert? Richard Kuntz talks about future neuro opportunities and the current challenges facing device clinical trials.
Are successful medical device start-ups born or made? It's not clear, but Stanford University's Emerging Entrepreneur program is attempting to incorporate the experience of successful start-ups in a hnew learning program.